Corvus Pharmaceuticals, Inc. (CRVS)
14.30
-0.41
(-2.79%)
USD |
NASDAQ |
Apr 07, 10:18
Corvus Pharmaceuticals SG&A Expense (TTM) : 9.252M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 2.70B |
| Plus Therapeutics, Inc. | 12.13M |
| Geron Corp. | 159.26M |
| Nektar Therapeutics | 68.67M |
| Jaguar Health, Inc. | 27.29M |